Sort   by:  
 Page size 
ProteomicsProteomic analysis of human alveolar bone
We optimised a sample preparation and analysis workflow for proteomic analysis of human alveolar bone. We compared the peptides and proteins extracted from bone by different buffers, then used a multi-enzyme, multi-search engine approach to increase proteome coverage.
ORGANISM(S): Homo sapiens (Human) 
2019-11-27 | PXD011524 | Pride
Human Bone Tails Shotgun Missing protein 
UnknownAn Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.
Not available
S-EPMC6876280 | biostudies-literature
UnknownSelective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation.
Not available
S-EPMC7610820 | biostudies-literature
UnknownTargeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
Not available
S-EPMC6586637 | biostudies-literature
UnknownCMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.
Not available
S-EPMC5706633 | biostudies-literature
UnknownA functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.
Not available
S-EPMC8642877 | biostudies-literature
UnknownBRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Not available
S-EPMC11299415 | biostudies-literature
UnknownEstimated Maternal Pesticide Exposure from Drinking Water and Heart Defects in Offspring.
Not available
S-EPMC5580593 | biostudies-literature
TranscriptomicsRNA expression data from primary neuroblastoma tumors
RNA expression profiles of 105 primary neuroblastomas derived from customized 4 x 44k oligonucleotide microarrays (Agilent Technologies). These profiles are part of an integrative study combining genomewide epigenetic profiles with transcriptome data of the same neuroblastoma cohort. Tumors were der...
ORGANISM(S): Homo sapiens 
2016-09-08 | E-GEOD-73517 | biostudies-arrayexpress
UnknownMethylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.
Not available
S-EPMC6162272 | biostudies-literature
Sort   by:  
 Page size